2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes

Core Clinical Principle: Osteoarthritis (OA) is no longer conceptualized as simple mechanical "wear and tear" of articular cartilage. Contemporary orthopaedic science defines OA as a multifactorial, progressive failure of the whole joint as an organ, involving articular cartilage breakdown, chondrocyte apoptosis, subchondral bone remodeling, osteophyte formation, ligamentous laxity, meniscal degeneration, and low-grade immune-mediated synovial inflammation.

---

Pathophysiology of Articular Cartilage Degradation

Healthy articular (hyaline) cartilage is an avascular, aneural, and alymphatic specialized connective tissue. Its extracellular matrix (ECM) is composed predominantly of Type II collagen fibrils (providing tensile strength), aggrecan proteoglycans bound to hyaluronic acid (providing compressive stiffness and osmotic hydration), and water (comprising 65% to 80% of total wet weight). Chondrocytes represent the sole resident cell type, responsible for maintaining ECM homeostasis.

Normal Cartilage Homeostasis: Anabolic Synthesis (Type II Collagen + Aggrecan) = Catabolic Turnover
                                       ↓ [Biomechanical Overload + Inflammatory Cascades]
OA Pathophysiologic State: Catabolic Breakdown (MMP-13 + ADAMTS-4/5) >> Anabolic Repair → Chondrocyte Apoptosis

Molecular & Enzymatic Cascades

In osteoarthritis, abnormal biomechanical loading and biochemical triggers initiate a destructive cascade:

1. Chondrocyte Activation & Phenotypic Shift: Quiescent chondrocytes transition to a hypertrophic, catabolic phenotype. They release pro-inflammatory cytokines, primarily interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), which bind to chondrocyte surface receptors in an autocrine and paracrine loop.
2. Upregulation of Matrix-Degrading Proteases:
   • Matrix Metalloproteinases (MMPs): Specifically MMP-13 (collagenase-3), along with MMP-1 and MMP-8, cleaves the triple helix of Type II collagen, causing irreversible structural disruption of the cartilage framework.
   • Aggrecanases (ADAMTS-4 and ADAMTS-5): A Disintegrin and Metalloproteinase with Thrombospondin Motifs enzymes cleave aggrecan at specific glutamate-alanine peptide bonds, causing loss of proteoglycan aggregates, decreased glycosaminoglycan (GAG) content, and loss of compressive water-binding capacity.
3. Cartilage Fibrillation & Fissuring: The superficial zone of cartilage develops microscopic disruptions (fibrillation), progressing to deep vertical clefts (fissuring) that extend through the transitional and radial zones toward the subchondral bone.
4. Chondrocyte Cloning & Apoptosis: Chondrocytes initially undergo abortive proliferative clustering ("cloning" or chondrone formation) in an attempt to repair matrix loss, followed by accelerated chondrocyte senescence and programmed cell death (apoptosis).
5. Tidemark Duplication & Cartilage Thinning: The calcified cartilage zone advances into the uncalcified hyaline cartilage, marked by duplication of the histological "tidemark" and progressive full-thickness articular cartilage loss.

---

Subchondral Bone Dynamics: Sclerosis, Eburnation, Cysts & Osteophytes

Articular cartilage and subchondral bone function as an integrated functional osteochondral unit. Cartilage loss alters load distribution across the subchondral plate, initiating dramatic structural bone remodeling:

---

Etiology & Risk Factor Stratification

Osteoarthritis is classified into Primary (Idiopathic) OA, which arises without an identifiable antecedent trigger, and Secondary OA, which develops secondary to known intra-articular trauma, infection, metabolic disease, or structural congenital deformity.

Primary Drivers of Osteoarthritis Development
├── Biomechanical Stresses
│   ├── Joint Malalignment (Genu Varum → Medial Knee OA; Genu Valgum → Lateral Knee OA)
│   ├── Post-Traumatic Intra-Articular Disruptions (ACL Tears, Meniscal Tears / Meniscectomy)
│   └── Repetitive Occupational Joint Overload (Heavy Lifting, Frequent Knee Bending)
└── Systemic & Metabolic Factors
    ├── Advanced Age (Cellular Senescence, Advanced Glycation End-products [AGEs])
    ├── Female Sex & Hormonal Changes (Postmenopausal Estrogen Decline)
    ├── Genetic Polymorphisms (GDF5, SMAD3, COL2A1 Gene Loci)
    └── Obesity & Adipokines (Compressive Load + Systemic Low-Grade Inflammation via Leptin & Resistin)

The Dual Biomechanical-Metabolic Impact of Obesity

Obesity influences osteoarthritis through two distinct, synergistic mechanisms:

1. Mechanical Overload: Every 1 pound of body weight transmits approximately 4 pounds of compressive force across the tibiofemoral joint during level ambulation, and up to 7 to 8 pounds during stair climbing.
2. Metabolic/Endocrine Signaling: Adipose tissue is an active endocrine organ secreting pro-inflammatory adipokines, including leptin, resistin, and visfatin, while suppressing anti-inflammatory adiponectin. Leptin crosses the blood-synovial barrier and stimulates chondrocytes and synovial fibroblasts to upregulate MMP-1, MMP-3, and MMP-13 expression. This explains the elevated prevalence of non-weight-bearing hand OA in obese individuals.

---

Kellgren-Lawrence (KL) Radiographic Grading System

The Kellgren-Lawrence system is the universal gold standard for classifying the radiographic severity of osteoarthritis on weight-bearing plain radiographs:

---

Clinical Manifestations & Nodal Hand Phenotypes

Clinical diagnosis of osteoarthritis integrates patient history, physical examination, and radiographic verification:

• Joint Pain: Typically insidious, aching, and mechanical—exacerbated by weight-bearing or joint use, and alleviated by rest. In advanced stages, pain occurs at rest and disrupts sleep.
• Morning Stiffness ("Gel Phenomenon"): Brief, transient stiffness following periods of inactivity, characteristically lasting less than 30 minutes (differentiating OA from rheumatoid arthritis, where morning stiffness typically exceeds 60 minutes).
• Crepitus & Decreased Range of Motion: Coarse, palpable grinding sensations during joint excursion due to irregular, roughened cartilaginous and bony contact surfaces.
• Joint Effusions: Mild, cool effusions resulting from low-grade synovial inflammation. Synovial fluid analysis reveals non-inflammatory fluid (clear/straw-colored, high viscosity, WBC count <2,000 cells/mcL, <25% polymorphonuclear leukocytes).

Hand Osteoarthritis Nodal Distribution:

    [DIP Joint] ─── Heberden Nodes (Distal Interphalangeal)
         │
    [PIP Joint] ─── Bouchard Nodes (Proximal Interphalangeal)
         │
    [MCP Joint] ─── Spared in Primary OA (Characteristic of RA)
         │
    [1st CMC Joint] ─ "Squaring" of the Thumb Base / First Metacarpal Joint

Heberden Nodes vs. Bouchard Nodes

• Heberden Nodes: Posterolateral bony and cartilaginous enlargements located at the distal interphalangeal (DIP) joints of the fingers. Associated with primary nodal generalized OA, strong familial predisposition, and female predominance.
• Bouchard Nodes: Hard, bony outgrowths located at the proximal interphalangeal (PIP) joints of the hands. Less common than Heberden nodes but signify widespread interphalangeal disease.
• First Carpometacarpal (CMC) Involvement: Degeneration at the trapeziometacarpal joint of the thumb base causes localized subluxation, tenderness, and a classic "squared" appearance of the hand, with positive grind test during axial compression and rotation.